Illumina Books Orders for More than 135 MiSeqs, Starts Early-Access Shipments | GenomeWeb

By Julia Karow

This article was originally published July 28.

Illumina has taken orders for more than 135 MiSeq instruments and has begun shipping the benchtop platform to early-access customers, the company said last week in a call to discuss its second-quarter financial results.

Second-quarter sequencing revenues grew more than 50 percent, largely driven by HiSeq 2000 sales, as the company reduced its backlog of orders for the system.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.